Fragile X Syndrome Research Study
Currently enrolling individuals age 3 to 22 years of age with Fragile X syndrome who are also experiencing behavioural-related issues.
Why is this Medical Research Study Important?
Individuals with FXS often experience behavioural symptoms such as anxiety (particularly social anxiety/avoidance), irritability, tantrums and social unresponsiveness, which can be challenging, not only for the individuals, but also their families. This investigational treatment may help to reduce these symptoms and has shown potentially promising results in prior studies.